Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana M Lopez

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Cancer Immunology, Immunotherapy : CII|May 8, 2009
Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing miceRoberto Carrio, Norman H Altman, Diana M Lopez
Breast Disease|February 3, 2005
T cell-derived matrix metalloproteinase-9 in breast cancer: friend or foe?Jennifer L Owen, Vijaya Iragavarapu-Charyulu, Diana M Lopez
International Journal of Molecular Medicine|November 5, 2015
Adipocyte and leptin accumulation in tumor-induced thymic involutionAlejandro Lamas, Elena Lopez, Roberto Carrio, et al.
Anticancer Research|May 23, 2002
Role of thymic stromal cell dysfunction in the thymic involution of mammary tumor-bearing miceQi-Ling Sun, Vijaya Charyulu, David Lobo, et al.
International Journal of Oncology|January 16, 2003
IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing miceMarta Torroella-Kouri, James C Keith, Milena Ivanova, et al.
International Journal of Oncology|December 18, 2010
Tumor-induced thymic atrophy: alteration in interferons and Jak/Stats signaling pathwaysRoberto Carrio, Marta Torroella-Kouri, Vijaya Iragavarapu-Charyulu, et al.
Cancer Genomics & Proteomics|August 10, 2019
Altered IL-12 Signaling Pathways Contribute to the Deficient IFN-γ Production by T Splenocytes from Tumor-bearing MiceMarta Torroella-Kouri, Lynn M Herbert, Giselle Perry, et al.
International Journal of Molecular Medicine|February 11, 2005
Diminished PKC activity and decreased binding of transcription factors are involved in the impaired production of nitric oxide by macrophages from tumor-bearing miceMichael R Di Napoli, Marta Torroella-Kouri, Giselle Perry, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2Joseph F Grosso, Lynn M Herbert, Jennifer L Owen, et al.
Cancer Research|April 3, 2008
Antitumor effects of Mucin 1/sec involves the modulation of urokinase-type plasminogen activator and signal transducer and activator of transcription 1 expression in tumor cellsDan Ilkovitch, Mary Ellen Handel-Fernandez, Lynn M Herbert, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|May 8, 2009
Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing miceRoberto Carrio, Norman H Altman, Diana M Lopez
Breast Disease|February 3, 2005
T cell-derived matrix metalloproteinase-9 in breast cancer: friend or foe?Jennifer L Owen, Vijaya Iragavarapu-Charyulu, Diana M Lopez
International Journal of Molecular Medicine|November 5, 2015
Adipocyte and leptin accumulation in tumor-induced thymic involutionAlejandro Lamas, Elena Lopez, Roberto Carrio, et al.
Anticancer Research|May 23, 2002
Role of thymic stromal cell dysfunction in the thymic involution of mammary tumor-bearing miceQi-Ling Sun, Vijaya Charyulu, David Lobo, et al.
International Journal of Oncology|January 16, 2003
IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing miceMarta Torroella-Kouri, James C Keith, Milena Ivanova, et al.
International Journal of Oncology|December 18, 2010
Tumor-induced thymic atrophy: alteration in interferons and Jak/Stats signaling pathwaysRoberto Carrio, Marta Torroella-Kouri, Vijaya Iragavarapu-Charyulu, et al.
Cancer Genomics & Proteomics|August 10, 2019
Altered IL-12 Signaling Pathways Contribute to the Deficient IFN-γ Production by T Splenocytes from Tumor-bearing MiceMarta Torroella-Kouri, Lynn M Herbert, Giselle Perry, et al.
International Journal of Molecular Medicine|February 11, 2005
Diminished PKC activity and decreased binding of transcription factors are involved in the impaired production of nitric oxide by macrophages from tumor-bearing miceMichael R Di Napoli, Marta Torroella-Kouri, Giselle Perry, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2Joseph F Grosso, Lynn M Herbert, Jennifer L Owen, et al.
Cancer Research|April 3, 2008
Antitumor effects of Mucin 1/sec involves the modulation of urokinase-type plasminogen activator and signal transducer and activator of transcription 1 expression in tumor cellsDan Ilkovitch, Mary Ellen Handel-Fernandez, Lynn M Herbert, et al.
Pageof 5